Gestational Hypothyroxinemia Affects Glutamatergic Synaptic Protein Distribution and Neuronal Plasticity Through Neuron-Astrocyte Interplay

Molecular Neurobiology

Volumn 53, Issue 10, 2016, Pages 7158-7169

  Cisternas, Pablo ^a   Louveau, Antoine ^b   Bueno, Susan M ^b,c   Kalergis, Alexis M ^b,c,d   Boudin, Hélène ^b,e   Riedel, Claudia A ^a  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e UNIVERSITÉ DE NANTES   (France)

Author keywords

Astrocyte; Gestational hypothyroxinemia; Glutamatergic synapse; Neuron

Indexed keywords

CD3 ANTIGEN; CD3 ZETA ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUN1 PROTEIN; GLYCINE; LIOTHYRONINE; NEUROPEPTIDE; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSIN I; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMIC ACID DERIVATIVE; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL FUNCTION; COCULTURE; CONTROLLED STUDY; EMBRYO; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GENE CLUSTER; GESTATIONAL AGE; GESTATIONAL HYPOTHYROXINEMIA; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; PREGNANCY DISORDERS OF ENDOCRINE ORIGIN; PROGENY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; WESTERN BLOTTING; ANIMAL; BLOOD; CELL COMMUNICATION; CELL COUNT; CYTOLOGY; DENDRITE; DRUG EFFECTS; METABOLISM; NERVE CELL; PREGNANCY; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT; SYNAPSE;

ANIMALS; ASTROCYTES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL COMMUNICATION; CELL COUNT; COCULTURE TECHNIQUES; DENDRITES; FEMALE; GLUTAMATES; GLYCINE; LONG-TERM POTENTIATION; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; PREGNANCY; PROTEIN TRANSPORT; RATS, SPRAGUE-DAWLEY; SYNAPSES; THYROXINE;

EID: 84950238597     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9609-0     Document Type: Article

References (75)

1. Delahunty C, Simpson J, Richard K, Coughtrie M, Williams F, Murphy N, Matthews T, Visser T et al (2001) Transient hypothyroxinaemia in preterm infants. Dev Med Child Neurol Suppl 86:26–27
2. Williams FL, Visser TJ, Hume R (2006) Transient hypothyroxinaemia in preterm infants. Early Human Dev 82(12):797–802. doi:10.1016/j.earlhumdev.2006.09.007
3. Wei W, Wang Y, Dong J, Min H, Song B, Teng W, Xi Q, Chen J (2013) Developmental hypothyroxinaemia induced by maternal mild iodine deficiency delays hippocampal axonal growth in the rat offspring. J Neuroendocrinol 25(9):852–862. doi:10.1111/jne.12058
4. Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2000) Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 85(11):3975–3987. doi:10.1210/jcem.85.11.6961
5. Morreale de Escobar G, Escobar del Rey F (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341(26):2015–2016, author reply 2017
6. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ (2003) Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 59(3):282–288
7. Pop VJ, Brouwers EP, Wijnen H, Oei G, Essed GG, Vader HL (2004) Low concentrations of maternal thyroxin during early gestation: a risk factor of breech presentation? BJOG: Int Jf Obstet Gynaecol 111(9):925–930. doi:10.1111/j.1471-0528.2004.00213.x
8. Pop VJ, Vulsma T (2005) Maternal hypothyroxinaemia during (early) gestation. Lancet 365(9471):1604–1606. doi:10.1016/S0140-6736(05)66489-6
9. Kooistra L, Crawford S, van Baar AL, Brouwers EP, Pop VJ (2006) Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatr 117(1):161–167. doi:10.1542/peds.2005-0227
10. Williams F, Hume R (2011) The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem 48(Pt 1):7–22. doi:10.1258/acb.2010.010174
11. Suarez-Rodriguez M, Azcona-San Julian C, Alzina de Aguilar V (2012) Hypothyroxinemia during pregnancy: the effect on neurodevelopment in the child. Int J Dev Neurosci: Off J IntSoc Dev Neurosci 30(6):435–438. doi:10.1016/j.ijdevneu.2012.07.004
12. Wang Y, Dong J, Wei W, Song B, Min H, Yu Y, Lei X, Zhao M et al (2014) Developmental hypothyroxinemia and hypothyroidism reduce proliferation of cerebellar granule neuron precursors in rat offspring by downregulation of the sonic hedgehog signaling pathway. Mol Neurobiol 49(3):1143–1152. doi:10.1007/s12035-013-8587-3
13. Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De Escobar G, Berbel P (2004) A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145(9):4037–4047. doi:10.1210/en.2004-0274
14. Lavado-Autric R, Auso E, Garcia-Velasco JV, Arufe Mdel C, Escobar del Rey F, Berbel P, Morreale de Escobar G (2003) Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Investig 111(7):1073–1082. doi:10.1172/JCI16262
15. Opazo MC, Gianini A, Pancetti F, Azkcona G, Alarcon L, Lizana R, Noches V, Gonzalez PA et al (2008) Maternal hypothyroxinemia impairs spatial learning and synaptic nature and function in the offspring. Endocrinology 149(10):5097–5106. doi:10.1210/en.2008-0560
16. Wang Y, Wei W, Dong J, Song B, Min H, Teng W, Chen J (2013) Neurotoxicity of developmental hypothyroxinemia and hypothyroidism in rats: impairments of long-term potentiation are mediated by phosphatidylinositol 3-kinase signaling pathway. Toxicol Appl Pharmacol 271(2):257–265. doi:10.1016/j.taap.2013.04.034
17. van Spronsen M, Hoogenraad CC (2010) Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Reports 10(3):207–214. doi:10.1007/s11910-010-0104-8
18. Willard SS, Koochekpour S (2013) Glutamate, glutamate receptors, and downstream signaling pathways. Int J Biol Sci 9(9):948–959. doi:10.7150/ijbs.6426
19. McAllister AK (2007) Dynamic aspects of CNS synapse formation. Annu Rev Neurosci 30:425–450. doi:10.1146/annurev.neuro.29.051605.112830
20. Ronan JL, Wu W, Crabtree GR (2013) From neural development to cognition: unexpected roles for chromatin. Nat Rev Genet 14(5):347–359. doi:10.1038/nrg3413
21. Pfrieger FW (2010) Role of glial cells in the formation and maintenance of synapses. Brain Res Rev 63(1–2):39–46. doi:10.1016/j.brainresrev.2009.11.002
22. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001) Control of synapse number by glia. Science 291(5504):657–661. doi:10.1126/science.291.5504.657
23. Ullian EM, Christopherson KS, Barres BA (2004) Role for glia in synaptogenesis. Glia 47(3):209–216. doi:10.1002/glia.20082
24. Ehlers MD (2005) Synapse formation: astrocytes spout off. Curr Biol: CB 15(4):R134–R137. doi:10.1016/j.cub.2005.02.013
25. Faissner A, Pyka M, Geissler M, Sobik T, Frischknecht R, Gundelfinger ED, Seidenbecher C (2010) Contributions of astrocytes to synapse formation and maturation—potential functions of the perisynaptic extracellular matrix. Brain Res Rev 63(1–2):26–38. doi:10.1016/j.brainresrev.2010.01.001
26. Perea G, Navarrete M, Araque A (2009) Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32(8):421–431. doi:10.1016/j.tins.2009.05.001
27. Navarrete M, Perea G, Fernandez de Sevilla D, Gomez-Gonzalo M, Nunez A, Martin ED, Araque A (2012) Astrocytes mediate in vivo cholinergic-induced synaptic plasticity. PLoS Biol 10(2):e1001259. doi:10.1371/journal.pbio.1001259
28. Perea G, Araque A (2010) GLIA modulates synaptic transmission. Brain Res Rev 63(1–2):93–102. doi:10.1016/j.brainresrev.2009.10.005
29. Perea G, Araque A (2005) Glial calcium signaling and neuron-glia communication. Cell Calcium 38(3–4):375–382. doi:10.1016/j.ceca.2005.06.015
30. Araque A, Perea G (2004) Glial modulation of synaptic transmission in culture. Glia 47(3):241–248. doi:10.1002/glia.20026
31. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF et al (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120(3):421–433. doi:10.1016/j.cell.2004.12.020
32. Kucukdereli H, Allen NJ, Lee AT, Feng A, Ozlu MI, Conatser LM, Chakraborty C, Workman G et al (2011) Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A 108(32):E440–E449. doi:10.1073/pnas.1104977108
33. Allen NJ, Bennett ML, Foo LC, Wang GX, Chakraborty C, Smith SJ, Barres BA (2012) Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486(7403):410–414. doi:10.1038/nature11059
34. Jones EV, Bernardinelli Y, Tse YC, Chierzi S, Wong TP, Murai KK (2011) Astrocytes control glutamate receptor levels at developing synapses through SPARC-beta-integrin interactions. J Neurosci: Off J Soc Neurosci 31(11):4154–4165. doi:10.1523/JNEUROSCI.4757-10.2011
35. Bredt DS, Nicoll RA (2003) AMPA receptor trafficking at excitatory synapses. Neuron 40(2):361–379
36. Jayakumar AR, Tong XY, Curtis KM, Ruiz-Cordero R, Shamaladevi N, Abuzamel M, Johnstone J, Gaidosh G et al (2014) Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: in vitro and in vivo studies. J Neurochem 131(3):333–347. doi:10.1111/jnc.12810
37. Jacobs S, Doering LC (2010) Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci: Off J Soc Neurosci 30(12):4508–4514. doi:10.1523/JNEUROSCI.5027-09.2010
38. Sloan SA, Barres BA (2014) Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders. Curr Opin Neurobiol 27:75–81. doi:10.1016/j.conb.2014.03.005
39. Ballas N, Lioy DT, Grunseich C, Mandel G (2009) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12(3):311–317. doi:10.1038/nn.2275
40. Jacobs S, Nathwani M, Doering LC (2010) Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci 11:132. doi:10.1186/1471-2202-11-132
41. Angibaud J, Louveau A, Baudouin SJ, Nerriere-Daguin V, Evain S, Bonnamain V, Hulin P, Csaba Z et al (2011) The immune molecule CD3zeta and its downstream effectors ZAP-70/Syk mediate ephrin signaling in neurons to regulate early neuritogenesis. J Neurochem 119(4):708–722. doi:10.1111/j.1471-4159.2011.07469.x
42. Louveau A, Angibaud J, Haspot F, Opazo MC, Thinard R, Thepenier V, Baudouin SJ, Lescaudron L et al (2013) Impaired spatial memory in mice lacking CD3zeta is associated with altered NMDA and AMPA receptors signaling independent of T-cell deficiency. J Neurosci: Off J Soc Neurosci 33(47):18672–18685. doi:10.1523/JNEUROSCI.3028-13.2013
43. Bykhovskaia M (2011) Synapsin regulation of vesicle organization and functional pools. Semin Cell Dev Biol 22(4):387–392. doi:10.1016/j.semcdb.2011.07.003
44. Han K, Kim E (2008) Synaptic adhesion molecules and PSD-95. Prog Neurobiol 84(3):263–283. doi:10.1016/j.pneurobio.2007.10.011
45. Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosci 5(10):771–781. doi:10.1038/nrn1517
46. Wenthold RJ, Prybylowski K, Standley S, Sans N, Petralia RS (2003) Trafficking of NMDA receptors. Annu Rev Pharmacol Toxicol 43:335–358. doi:10.1146/annurev.pharmtox.43.100901.135803
47. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6):413–426. doi:10.1038/nrn2153
48. Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT (2001) Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29(1):243–254
49. Liao D, Scannevin RH, Huganir R (2001) Activation of silent synapses by rapid activity-dependent synaptic recruitment of AMPA receptors. J Neurosci: Off J Soc Neurosci 21(16):6008–6017
50. Oh MC, Derkach VA (2005) Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII. Nat Neurosci 8(7):853–854. doi:10.1038/nn1476
51. Sharma K, Fong DK, Craig AM (2006) Postsynaptic protein mobility in dendritic spines: long-term regulation by synaptic NMDA receptor activation. Mol Cell Neurosci 31(4):702–712. doi:10.1016/j.mcn.2006.01.010
52. Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14(6):383–400. doi:10.1038/nrn3504
53. McIlhinney RA, Philipps E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S, Whiting P (2003) Assembly of N-methyl-D-aspartate (NMDA) receptors. Biochem Soc Trans 31(Pt 4):865–868
54. Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, Gruca P, Papp M et al (2014) Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits. Int J Neuropsychopharm 17(3):393–405. doi:10.1017/S1461145713001089
55. Lisman J, Yasuda R, Raghavachari S (2012) Mechanisms of CaMKII action in long-term potentiation. Nat Rev Neurosci 13(3):169–182. doi:10.1038/nrn3192
56. Groth RD, Lindskog M, Thiagarajan TC, Li L, Tsien RW (2011) Beta Ca2+/CaM-dependent kinase type II triggers upregulation of GluA1 to coordinate adaptation to synaptic inactivity in hippocampal neurons. Proc Natl Acad Sci U S A 108(2):828–833. doi:10.1073/pnas.1018022108
57. Sanhueza M, Fernandez-Villalobos G, Stein IS, Kasumova G, Zhang P, Bayer KU, Otmakhov N, Hell JW et al (2011) Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. J Neurosci: Off J Soc Neurosci 31(25):9170–9178. doi:10.1523/JNEUROSCI.1250-11.2011
58. Molnar E (2011) Long-term potentiation in cultured hippocampal neurons. Semin Cell Dev Biol 22(5):506–513. doi:10.1016/j.semcdb.2011.07.017
59. Pavlov I, Lauri S, Taira T, Rauvala H (2004) The role of ECM molecules in activity-dependent synaptic development and plasticity. Birth Defects Res Part C Embryo Today: Rev 72(1):12–24. doi:10.1002/bdrc.20001
60. Farwell AP, Dubord-Tomasetti SA (1999) Thyroid hormone regulates the extracellular organization of laminin on astrocytes. Endocrinology 140(11):5014–5021. doi:10.1210/endo.140.11.7114
61. Mendes-de-Aguiar CB, Alchini R, Zucco JK, Costa-Silva B, Decker H, Alvarez-Silva M, Tasca CI, Trentin AG (2010) Impaired astrocytic extracellular matrix distribution under congenital hypothyroidism affects neuronal development in vitro. J Neurosci Res 88(15):3350–3360. doi:10.1002/jnr.22481
62. Xu J, Xiao N, Xia J (2010) Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat Neurosci 13(1):22–24. doi:10.1038/nn.2459
63. Patel VA, Hill DJ, Eggo MC, Sheppard MC, Becks GP, Logan A (1996) Changes in the immunohistochemical localisation of fibroblast growth factor-2, transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid. J Endocrinol 148(3):485–499
64. Calloni GW, Alvarez-Silva M, Vituri C, Trentin AG (2001) Thyroid hormone deficiency alters extracellular matrix protein expression in rat brain. Brain Res Dev Brain Res 126(1):121–124
65. Diniz LP, Almeida JC, Tortelli V, Vargas Lopes C, Setti-Perdigao P, Stipursky J, Kahn SA, Romao LF et al (2012) Astrocyte-induced synaptogenesis is mediated by transforming growth factor beta signaling through modulation of D-serine levels in cerebral cortex neurons. J Biol Chem 287(49):41432–41445. doi:10.1074/jbc.M112.380824
66. Heupel K, Sargsyan V, Plomp JJ, Rickmann M, Varoqueaux F, Zhang W, Krieglstein K (2008) Loss of transforming growth factor-beta 2 leads to impairment of central synapse function. Neural Dev 3:25. doi:10.1186/1749-8104-3-25
67. Akinci B, Comlekci A, Yener S, Bayraktar F, Demir T, Ozcan MA, Yuksel F, Yesil S (2008) Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels. Arch Med Res 39(4):397–401. doi:10.1016/j.arcmed.2007.12.001
68. Patel J, Landers K, Li H, Mortimer RH, Richard K (2011) Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metabolism: TEM 22(5):164–170. doi:10.1016/j.tem.2011.02.002
69. Leonard JL (2008) Non-genomic actions of thyroid hormone in brain development. Steroids 73(9–10):1008–1012. doi:10.1016/j.steroids.2007.12.016
70. Davis PJ, Davis FB, Cody V (2005) Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab: TEM 16(9):429–435. doi:10.1016/j.tem.2005.09.007
71. Trentin AG (2006) Thyroid hormone and astrocyte morphogenesis. J Endocrinol 189(2):189–197. doi:10.1677/joe.1.06680
72. Shi Y, Ethell IM (2006) Integrins control dendritic spine plasticity in hippocampal neurons through NMDA receptor and Ca2+/calmodulin-dependent protein kinase II-mediated actin reorganization. J Neurosci: Off J Soc Neurosci 26(6):1813–1822. doi:10.1523/JNEUROSCI.4091-05.2006
73. Scapin S, Leoni S, Spagnuolo S, Gnocchi D, De Vito P, Luly P, Pedersen JZ, Incerpi S (2010) Short-term effects of thyroid hormones during development: focus on signal transduction. Steroids 75(8–9):576–584. doi:10.1016/j.steroids.2009.10.013
74. Hsu JH, Brent GA (1998) Thyroid hormone receptor gene knockouts. Trends Endocrinol Metab: TEM 9(3):103–112
75. Dong H, You SH, Williams A, Wade MG, Yauk CL, Thomas Zoeller R (2015) Transient maternal hypothyroxinemia potentiates the transcriptional response to exogenous thyroid hormone in the fetal cerebral cortex before the onset of fetal thyroid function: a messenger and microRNA profiling study. Cereb Cortex 25(7):1735–1745. doi:10.1093/cercor/bht364